Apricus Elects Kleanthis G. Xanthopoulos, Ph.D. as New Chairman
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/12/2026
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Dell shares surge on record AI server bookings
- 'No panic anywhere' may be the problem, BofA strategists warn
- Kroger cuts same-store sales outlook, keeps earnings guidance
- AstraZeneca's camizestrant fails primary endpoint in breast cancer trial
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Apricus Biosciences (APRI) Appoints Kleanthis Xanthopoulos as Chairman
December 11, 2013 7:07 AM ESTApricus Biosciences, Inc. (Nasdaq: APRI) announced that Kleanthis G. Xanthopoulos, Ph.D. has been elected as Chairman of the Company's Board of Directors. Dr. Xanthopoulos succeeds Mr. Rusty Ray in the Chairman role. Mr. Ray will continue to serve as a Director and will assume key roles on the Company's audit, compensation and corporate governance committees of the Board. Dr. Xanthopoulos has been a member of the Apricus Board since 2011.
"I am honored to be elected Chairman of the Apricus Board of Directors during this pivotal point in the Company's evolution," said Dr. Xanthopoulos.... More
